Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance

Jie Sun1, Qi Shen2, Haiqi Lu2

  • 1Laboratory of Cancer Biology, Provincial Key Lab of Biotherapy in Zhejiang, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China.

Oncotarget
|November 7, 2015
PubMed

Insights

Ras activation in cancer suppresses thymine-DNA glycosylase (TDG) by inhibiting ING4. Restoring TDG reactivates Fas, restoring apoptosis sensitivity and suppressing pancreatic cancer growth.

Area of Science:

  • Molecular oncology
  • Epigenetics
  • Cancer biology

Background:

  • Aberrant Ras activation is common in many cancers.
  • DNA demethylation is crucial for cancer development.
  • The role of Ras in regulating DNA demethylation during carcinogenesis was unclear.

Purpose of the Study:

  • To investigate the mechanism by which Ras regulates DNA demethylation in cancer.
  • To explore the role of thymine-DNA glycosylase (TDG) in Ras-driven carcinogenesis.

Main Methods:

  • Investigated Ras's effect on TDG expression and activity.
  • Analyzed the interaction between ING4, TDG, and the TDG promoter.
  • Examined TDG's role in recruiting JMJD3 to the Fas promoter.
  • Assessed the impact of TDG on Fas expression and apoptosis sensitivity.
  • Evaluated TDG's effect on xenograft pancreatic cancer tumorigenicity.

Main Results:

  • Ras was found to downregulate thymine-DNA glycosylase (TDG).
  • Ras inhibited the interaction between transcription activator ING4 and the TDG promoter.
  • TDG recruited histone lysine demethylase JMJD3 to the Fas promoter, activating its expression.
  • TDG restored sensitivity to apoptosis and suppressed in vivo tumorigenicity of xenograft pancreatic cancer.

Conclusions:

  • Ras-mediated inhibition of ING4 suppresses TDG expression.
  • Restoring TDG function can reactivate Fas expression and apoptosis.
  • Targeting the Ras-ING4-TDG-Fas pathway may offer a therapeutic strategy for Ras-driven cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K